| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $23.28M | $40.18M | $61.42M | $86.05M | $117.67M |
| SG&A | $19.88M | $24.99M | $41.58M | $49.34M | $60.06M |
| Operating Income | -$49.30M | -$70.40M | -$108.39M | -$138.39M | -$185.73M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$45.52M | -$64.77M | -$102.06M | -$136.13M | -$185.39M |
| EPS (basic) | -14.3500 | -1.0700 | -1.8600 | -2.5000 | -3.4800 |
| EPS (diluted) | -14.3500 | -1.0700 | -1.8600 | -2.5000 | -3.4800 |
| Shares (diluted) | $3.17M | $60.41M | $54.74M | $54.43M | $53.34M |